The Centers for Disease Control and Prevention have onboarded state and jurisdictional health departments to use a more detailed form of COVID-19 electronic laboratory reporting (CELR).
As of Aug. 7, 38 jurisdictions have converted to CELR, representing more than 74 percent of total lab testing volume in the United States.
HHS Announces Partnerships to Create COVID-19 Investigational Vaccines
Through Operation Warp Speed, the Department of Health and Human Services (HHS), along with several other federal agencies, will collaborate with Janssen Pharmaceutical Companies of Johnson & Johnson for large-scale manufacturing and delivery of the company’s COVID-19 vaccine candidate.
Under this partnership, the federal government will own the resulting 100 million doses of vaccine, which could be used in clinical trials. If the U.S. Food and Drug Administration (FDA) authorizes use, the doses could be distributed through a COVID-19 vaccination campaign.
Operation Warp Speed aims to accelerate vaccine development and facilitate a tiered approach to vaccine and therapeutic distribution. HHS also awarded funding to Moderna, AstraZeneca, Regeneron, Novavax, Sanofi, and GlaxoSmithKline. The most promising candidates will conduct large-scale randomized trials to demonstrate safety and efficacy.
Visit the America’s Essential Hospitals coronavirus resource page for more information about the outbreak.
Contact Senior Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.
